Craneware plc CRW
LSE · United Kingdom · Technology Services
GBp 1,066.00-24.00 (-2.20%)
Market closed· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
The healthcare-software group plunged after cyber fallout and disruption to America’s 340B drug-pricing market forced management to slash near-term revenue expectations.
As the reliance on technology increases, healthcare leaders need to invest heavily in cyber-protection measures.
Edinburgh-based tech firm Craneware said customer data was stolen during a cyberattack. The company makes software that thousands of U.S. hospitals, pharmacies, and clinics rely on for billing patients, potentially exposing health data.
The Craneware Group (AIM: CRW.L), a leader in healthcare financial and operational performance solutions, today introduced Medication Reimbursement Intelligence, its strategic framework for helping health systems manage medication reimbursement as a connected financial system.
The Craneware Group will showcase sustained enterprise financial performance leadership at HIMSS Global Health Conference & Exhibition, highlighted by its 15th Best in KLAS® recognition for Trisus Chargemaster and expanded AI capabilities embedded across the Trisus® platform.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.